Product Information
PROGESTERONE 100 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2290 per EA under NDC 59651015201. Its NADAC has been published 366 times since Oct 2, 2019.
FDA first approved this application on Oct 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651015201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROGESTERONEApproval Type
Generic (ANDA)
FDA Application
ANDA211285FDA Approved
10/26/2018
TE Code
AB
On Market Since
10/26/2018
Pharmacological Classes
Price Statistics
The NADAC for PROGESTERONE 100 MG CAPSULE has been published 366 times since Oct 2, 2019, and over the history we have for it it has declined 44.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2290 per EA |
|---|---|
| All-time high | $0.4757 (Jun 10, 2020) |
| All-time low | $0.1797 (Nov 20, 2024) |
| 52-week high | $0.2417 |
| 52-week low | $0.2114 |
| Median price | $0.2527 |
| Average price | $0.2806 |
| Largest weekly change | +54.5% (Jun 19, 2024) |
| Weeks tracked | 366 |
| Tracking since | Oct 2, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Progesterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progesterone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROGESTERONE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PROGESTERONE 100 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.2290 per EA (NDC 59651015201), effective Sep 30, 2026.
How has the price of PROGESTERONE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PROGESTERONE 100 MG CAPSULE has declined 44.5%. It has been tracked across 366 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for PROGESTERONE 100 MG CAPSULE?
Since Oct 2, 2019, the NADAC for PROGESTERONE 100 MG CAPSULE has ranged from a low of $0.1797 (Nov 20, 2024) to a high of $0.4757 (Jun 10, 2020), with a median of $0.2527 per EA.
Are there cheaper alternatives to PROGESTERONE 100 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROGESTERONE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PROGESTERONE 100 MG CAPSULE?
PROGESTERONE 100 MG CAPSULE (NDC 59651015201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.